BioCentury | Nov 25, 2019
Clinical News
Months after NASH failure, more woes for CymaBay's lead product on safety
...from an immunoallergic or inflammatory process. CymaBay has two remaining products: GPR119 agonist MBX-2982 and GPR120...
...I for NASH and NAFLD. Targets: GPR119 - G protein-coupled receptor 119; GPR120 (O3FAR1) - G protein-coupled receptor 120...
...I for NASH and NAFLD. Targets: GPR119 - G protein-coupled receptor 119; GPR120 (O3FAR1) - G protein-coupled receptor 120...